CSIMarket


Moderna Inc   (MRNA)
Other Ticker:  
 

Moderna Inc

MRNA's Fundamental analysis






Looking into Moderna Inc growth rates, revenue grew by 6462.07 % in II. Quarter 2021 from the same quarter a year ago. Ranking at No. 25

Biotechnology & Pharmaceuticals industry recorded growth of revenues by 41.33 %

Moderna Inc realized net income compared to net loss a year ago in II. Quarter 2021

More on MRNA's Growth


Moderna Inc
current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.

Moderna Inc PEG ratio is at -0.06 , above Biotechnology & Pharmaceuticals industry PEG average of 0.
Company
40.41
PE TTM   
Industry
0
PE TTM    
Company's Price to Sales ratio is at 19.91.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.92.

Moderna Inc Price to Book Ratio is at 20.84 lower than Indusry Avg. of 1361.03. and higher than S&P 500 Avg. of -0

More on MRNA's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 4.12
 Tangible Book Value (Per Share $) 15.55

Moderna Inc
current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.

Moderna Inc PEG ratio is at -0.06 , above Biotechnology & Pharmaceuticals industry PEG average of 0.
Company
40.41
PE TTM   
Industry
0
PE TTM    
Company's Price to Sales ratio is at 19.91.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.92.

Moderna Inc Price to Book Ratio is at 20.84 lower than Indusry Avg. of 1361.03. and higher than S&P 500 Avg. of -0

More on MRNA's Valuation

  Market Capitalization (Millions $) 139,735
  Shares Outstanding (Millions) 431
  Employees -
  Revenues (TTM) (Millions $) 7,020
  Net Income (TTM) (Millions $) 3,495
  Cash Flow (TTM) (Millions $) 3,840
  Capital Exp. (TTM) (Millions $) -108
  Total Debt (Millions $) -
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 4.12
  Tangible Book Value (Per Share $) 15.55

  Market Capitalization (Millions $) 139,735
  Shares Outstanding (Millions) 431
  Employees -
  Revenues (TTM) (Millions $) 7,020
  Net Income (TTM) (Millions $) 3,495
  Cash Flow (TTM) (Millions $) 3,840
  Capital Exp. (TTM) (Millions $) -108

MRNA's Profitability Comparisons
Moderna Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in II. Quarter 2021 to 70.33 % from 65.36 % in I. Quarter.

Moderna Inc net profit margin of 63.85 % is currently ranking no. 5 in Biotechnology & Pharmaceuticals industry, ranking no. 21 in Healthcare sector and number 183 in S&P 500.





  Ratio
   Capital Ratio (MRQ) 1.24
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) 1.41
  Asset Turnover Ratio (TTM) 0.69
  Inventory Turnover Ratio (TTM) 3.21



Moderna Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in II. Quarter 2021 to 70.33 % from 65.36 % in I. Quarter.

Moderna Inc net profit margin of 63.85 % is currently ranking no. 5 in Biotechnology & Pharmaceuticals industry, ranking no. 21 in Healthcare sector and number 183 in S&P 500.

More on MRNA's Key Ratios





       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

DSAC's Profile

Stock Price

DSAC's Financials

Business Description

Fundamentals

Charts & Quotes

DSAC's News

Suppliers

DSAC's Competitors

Customers & Markets

Economic Indicators

DSAC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071